Church & Dwight (CHD) just posted a sizeable turnaround in their third quarter results, swinging from a loss last year to a strong net profit. The company also lifted its full-year outlook and expects ...

Amgen (NASDAQ:AMGN) today announced detailed results from the Phase 3 VESALIUS-CV clinical trial, which showed that Repatha® (evolocumab) achieved statistically significant and clinically meaningful ...